scholarly journals Low Risk of Ipsilateral Stroke in Patients With Asymptomatic Carotid Stenosis on Best Medical Treatment

Stroke ◽  
2010 ◽  
Vol 41 (1) ◽  
Author(s):  
Lars Marquardt ◽  
Olivia C. Geraghty ◽  
Ziyah Mehta ◽  
Peter M. Rothwell
Vascular ◽  
2014 ◽  
Vol 23 (1) ◽  
pp. 62-64 ◽  
Author(s):  
Kosmas I Paraskevas ◽  
Andrew N Nicolaides ◽  
Frank J Veith

Several guidelines recommend carotid endarterectomy for patients with severe asymptomatic carotid stenosis to reduce the risk of a future cerebrovascular event, as long as the perioperative stroke/death rate is <3%. Based on improvements in best medical treatment, it was argued that currently best medical treatment alone should comprise the treatment-of-choice for asymptomatic carotid stenosis patients and that no intervention is warranted in these individuals. While it is true that best medical treatment should be used for the management of all asymptomatic carotid stenosis patients, emerging evidence suggests that best medical treatment alone may not prevent disease progression and the development of symptoms in some asymptomatic carotid stenosis patient subgroups. This article analyzes the results of two recent independent studies demonstrating that medical therapy alone may not be adequate for stroke prevention in some asymptomatic carotid stenosis patient subgroups. These results suggest that besides best medical treatment, additional carotid endarterectomy should be considered for specific asymptomatic carotid stenosis patients.


Angiology ◽  
2015 ◽  
Vol 67 (5) ◽  
pp. 408-410 ◽  
Author(s):  
Wesley S. Moore

The superiority of carotid endarterectomy (CEA) plus best medical treatment (BMT) over BMT alone for the management of patients with asymptomatic carotid stenosis is based on randomized controlled trials that recruited patients up to 30 years ago. Best medical treatment has improved considerably since that time with respect to stroke prevention. Furthermore, a new carotid intervention has emerged during the last 2 decades and has gradually become established, that is, carotid artery stenting (CAS). Consequently, the efficacy of current BMT alone needs to be compared not only with CEA plus BMT but also with CAS plus BMT to determine which strategy achieves the optimal stroke prevention rates. This article highlights the purpose of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2 and discusses the issues that CREST-2 will hopefully provide answers to.


Stroke ◽  
2005 ◽  
Vol 36 (11) ◽  
pp. 2373-2378 ◽  
Author(s):  
J. David Spence ◽  
Arturo Tamayo ◽  
Stephen P. Lownie ◽  
Wai P. Ng ◽  
Gary G. Ferguson

Sign in / Sign up

Export Citation Format

Share Document